Clinical Trial Update: Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating whether neoadjuvant low-dose radiation can modulate tumor-infiltrating T cells in colorectal cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer with Liver Metastases

Snippet

Sponsor: Heidelberg University | Conditions: Colorectal Liver Metastases | Phase 1, Phase 2 | Status: UNKNOWN